The global skin cancer treatment market generated $7.2 billion in 2021, and is estimated to reach $14.5 billion by 2031, manifesting a CAGR of 7.3% from 2022 to 2031. Skin cancer is the most prevalent type of cancer across the globe. Melanoma or non-melanoma skin cancer (NMSC) are the two main categories of skin cancer. Due to …